Literature DB >> 25330927

Dependence scale for Alzheimer's disease: relationship with other clinical indicators and psychometric properties.

Josep Garre-Olmo1, Joan Vilalta-Franch2, Laia Calvó-Perxas3, Sílvia Monserrat-Vila3, Secundino López-Pousa2.   

Abstract

The objective of this cross-sectional and multicenter study was to evaluate the psychometric properties of the Spanish version of the Dependence Scale (DS) and to assess the relationship between dependence and clinical measures according to disease severity. Medical comorbidities, cognitive status and functional status, behavior, dependence, caregiver burden, and medical and social resources were assessed using standardized instruments. The sample consisted of 343 patients (32.1% mild, 36.7% moderate, and 31.2% severe), the mean age was 78.9 years (standard deviation=7.4), and 67.0% were women. Criterion and construct validity index of DS were appropriate. The DS standard error of measurement was ±1.23. The explained variance in DS ranged between 0.598 and 0.731, and the relative contribution of clinical measures depended on disease severity. Current findings confirm that the Spanish version of the DS has appropriate psychometric indices and suggest that clinical indicators have different contribution to dependence according to disease severity.
© The Author(s) 2014.

Entities:  

Keywords:  Alzheimer disease; Dependence Scale; dementia; dependence; disease progression; psychometrics

Mesh:

Year:  2014        PMID: 25330927     DOI: 10.1177/0891988714554711

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  2 in total

1.  Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.

Authors:  Tzeyu L Michaud; Robin High; Mary E Charlton; Daniel L Murman
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

Review 2.  Utility of the Dependence Scale in dementia: validity, meaningfulness, and health economic considerations.

Authors:  Carolyn W Zhu; Bote Gosse Bruinsma; Yaakov Stern
Journal:  Alzheimers Res Ther       Date:  2018-08-13       Impact factor: 6.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.